Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies

Hepatol Int. 2023 Apr;17(2):509-511. doi: 10.1007/s12072-022-10462-0. Epub 2022 Dec 7.

¹ Department of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, TX, USA.
² Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1460, Houston, TX, 77030, USA.
³ Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁶ Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1460, Houston, TX, 77030, USA. htorres@mdanderson.org.
⁸ Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. htorres@mdanderson.org.

No abstract available

Publication types